Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis.

Behrouz R, Topel CH, Seifi A, Birnbaum LA, Brey RL, Misra V, Di Napoli M.

J Neurovirol. 2016 Oct;22(5):634-640. Epub 2016 Apr 4. Review.

PMID:
27044037
2.

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.

Amory CF, Levine SR, Brey RL, Gebregziabher M, Tuhrim S, Tilley BC, Simpson AC, Sacco RL, Mohr JP; APASS-WARSS Collaborators.

Cerebrovasc Dis. 2015;40(5-6):293-300. doi: 10.1159/000441362. Epub 2015 Oct 29.

3.

Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Capuano AW, Yu L, Leurgans SE, Bennett DA, Levine SR.

Circulation. 2015 Jan 13;131(2):182-9. doi: 10.1161/CIRCULATIONAHA.114.012479. Epub 2014 Oct 9.

4.

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Longstreth WT Jr, Kronmal RA, Thompson JL, Christenson RH, Levine SR, Gross R, Brey RL, Buchsbaum R, Elkind MS, Tirschwell DL, Seliger SL, Mohr JP, deFilippi CR.

Stroke. 2013 Mar;44(3):714-9. doi: 10.1161/STROKEAHA.112.675942. Epub 2013 Jan 22.

5.

Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Leurgans SE, Yu L, Buchman AS, Arfanakis K, Fleischman DA, Boyle PA, Bennett DA, Levine SR.

Neuroepidemiology. 2013;40(2):73-84. doi: 10.1159/000342761. Epub 2012 Oct 24.

6.

Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.

Ramage AE, Fox PT, Brey RL, Narayana S, Cykowski MD, Naqibuddin M, Sampedro M, Holliday SL, Franklin C, Wallace DJ, Weisman MH, Petri M.

Arthritis Rheum. 2011 Oct;63(10):3048-57. doi: 10.1002/art.30458.

7.

Antiphospholipid antibodies and the brain: a consensus report.

Brey RL, Muscal E, Chapman J.

Lupus. 2011 Feb;20(2):153-7. doi: 10.1177/0961203310396748.

PMID:
21303831
8.

International consensus for a definition of disease flare in lupus.

Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sánchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT; Lupus Foundation of America, Inc. International Flare Consensus Initiative.

Lupus. 2011 Apr;20(5):453-62. doi: 10.1177/0961203310388445. Epub 2010 Dec 10.

PMID:
21148601
9.

Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus.

Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Padilla PA, Brey RL.

J Rheumatol. 2010 Oct;37(10):2032-8. doi: 10.3899/jrheum.091366. Epub 2010 Jul 15.

PMID:
20634244
10.

Cerebral and cerebellar volume loss in children and adolescents with systemic lupus erythematosus: a review of clinically acquired brain magnetic resonance imaging.

Muscal E, Traipe E, de Guzman MM, Myones BL, Brey RL, Hunter JV.

J Rheumatol. 2010 Aug 1;37(8):1768-75. doi: 10.3899/jrheum.090983. Epub 2010 Jun 1.

PMID:
20516022
11.

Antiphospholipid syndrome and the brain in pediatric and adult patients.

Muscal E, Brey RL.

Lupus. 2010 Apr;19(4):406-11. doi: 10.1177/0961203309360808. Review.

12.

MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.

Muscal E, Traipe E, de Guzman MM, Myones BL, Brey RL, Hunter JV.

Pediatr Radiol. 2010 Jul;40(7):1241-5. doi: 10.1007/s00247-009-1540-y. Epub 2010 Jan 30.

PMID:
20119723
13.

Neurologic manifestations of systemic lupus erythematosus in children and adults.

Muscal E, Brey RL.

Neurol Clin. 2010 Feb;28(1):61-73. doi: 10.1016/j.ncl.2009.09.004. Review.

14.

Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.

Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, Sacco RL, Thompson JL, Mohr JP, Levine SR; PICSS-APASS Investigators.

Stroke. 2009 Jul;40(7):2337-42. doi: 10.1161/STROKEAHA.108.539171. Epub 2009 Jun 4.

15.

Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.

Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Narayana S, Fox PT, Franklin C, Padilla PA, Brey RL.

J Rheumatol. 2008 Dec;35(12):2348-54. Epub 2008 Sep 15.

16.

Cognitive function in a systemic lupus erythematosus inception cohort.

Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL.

J Rheumatol. 2008 Sep;35(9):1776-81. Epub 2008 Jul 15.

PMID:
18634154
17.

Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.

Muscal E, Brey RL.

Curr Rheumatol Rep. 2008 Jan;10(1):67-73. Review.

PMID:
18457615
18.

Neuropsychiatric lupus: clinical and imaging aspects.

Brey RL.

Bull NYU Hosp Jt Dis. 2007;65(3):194-9. Review.

19.

Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.

Muscal E, Brey RL.

Int J Clin Pract. 2007 Sep;61(9):1561-8. Epub 2007 Jun 26. Review.

PMID:
17596187
20.

Neurologic manifestations of the antiphospholipid syndrome.

Roldan JF, Brey RL.

Curr Rheumatol Rep. 2007 May;9(2):109-15. Review.

PMID:
17502040
21.

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA.

J Thromb Haemost. 2006 Feb;4(2):295-306.

22.

Antiphospholipid antibodies in young adults with stroke.

Brey RL.

J Thromb Thrombolysis. 2005 Oct;20(2):105-12. Review.

PMID:
16205859
23.
24.

Patient page. Exercise is safe and beneficial for people with facioscapulohumeral muscular dystrophy.

Brey RL.

Neurology. 2005 Mar 22;64(6):E22. No abstract available.

PMID:
15781802
25.

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.

McLaurin EY, Holliday SL, Williams P, Brey RL.

Neurology. 2005 Jan 25;64(2):297-303.

PMID:
15668428
26.

Patient page. Long-term obesity is linked to loss of brain tissue.

Brey RL.

Neurology. 2004 Nov 23;63(10):E19-20. No abstract available.

PMID:
15557485
27.

Management of the neurological manifestations of APS--what do the trials tell us?

Brey RL.

Thromb Res. 2004;114(5-6):489-99. Review.

PMID:
15507283
28.
29.

Patient Page. Clinical research needs YOU to help develop new cures!

Brey RL.

Neurology. 2004 Jul 13;63(1):E1. No abstract available.

PMID:
15249650
30.

Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage.

Zaccagni H, Fried J, Cornell J, Padilla P, Brey RL.

Front Biosci. 2004 May 1;9:1654-9.

PMID:
14977576
31.

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators.

JAMA. 2004 Feb 4;291(5):576-84.

PMID:
14762036
32.

Patient page. Cigarette smoking and multiple sclerosis (MS): yet another reason to quit.

Brey RL.

Neurology. 2003 Oct 28;61(8):E11-2. No abstract available.

PMID:
14581703
33.

Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.

Tanne D, Levine SR, Brey RL, Lin H, Tilley BC; NINDS rt-PA Stroke Study Group.

Neurology. 2003 Oct 28;61(8):1158-9. No abstract available.

PMID:
14581697
34.

Validating a computerized neuropsychological test battery for mixed ethnic lupus patients.

Holliday SL, Navarrete MG, Hermosillo-Romo D, Valdez CR, Saklad AR, Escalante A, Brey RL.

Lupus. 2003;12(9):697-703.

PMID:
14514133
35.

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.

Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y.

Lupus. 2003;12(7):514-7. Review.

PMID:
12892390
36.

Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.

Brey RL, Chapman J, Levine SR, Ruiz-Irastorza G, Derksen RH, Khamashta M, Shoenfeld Y.

Lupus. 2003;12(7):508-13. Review.

PMID:
12892389
37.

Neuropsychiatric systemic lupus erythematosus: miles to go before we sleep.

Brey RL, Petri MA.

Neurology. 2003 Jul 8;61(1):9-10. No abstract available.

PMID:
12847148
38.

Patient page. Memory problems after epilepsy surgery.

Holliday SL, Brey RL.

Neurology. 2003 Mar 25;60(6):E3-5. No abstract available.

PMID:
12654994
39.

Severe neurologic complications after hematopoietic (peripheral blood) stem cell transplantation in children.

Brey RL.

Neurology. 2002 Dec 24;59(12):E13-5. No abstract available.

PMID:
12499515
40.

Antiphospholipid antibodies and stroke in young women.

Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ.

Stroke. 2002 Oct;33(10):2396-400.

PMID:
12364727
41.

Neuropsychiatric involvement in systemic lupus erythematosus.

Hermosillo-Romo D, Brey RL.

Curr Rheumatol Rep. 2002 Aug;4(4):337-44. Review.

PMID:
12126586
42.

Patient page. Blood pressure control and stroke: an ounce of prevention is worth a pound of cure.

Leonard AD, Brey RL.

Neurology. 2002 Jul 9;59(1):E1-2. No abstract available.

PMID:
12105335
43.

Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).

Hermosillo-Romo D, Brey RL.

Best Pract Res Clin Rheumatol. 2002 Apr;16(2):229-44. Review.

PMID:
12041951
44.

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincón I, Gronseth G, Rhine CB, Padilla P, McGlasson D.

Neurology. 2002 Apr 23;58(8):1214-20.

PMID:
11971089
45.

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program.

Brey RL, Abbott RD, Curb JD, Sharp DS, Ross GW, Stallworth CL, Kittner SJ.

Stroke. 2001 Aug;32(8):1701-6.

PMID:
11486093
46.

Neuropsychiatric Systemic Lupus Erythematosus.

Navarrete MG, Brey RL.

Curr Treat Options Neurol. 2000 Sep;2(5):473-485.

PMID:
11096772
47.
48.

Neurological manifestations of antiphospholipid antibody syndrome.

Brey RL, Escalante A.

Lupus. 1998;7 Suppl 2:S67-74. Review.

PMID:
9814677
49.

Animal models for nervous system disease in systemic lupus erythematosus.

Brey RL, Sakic B, Szechtman H, Denburg JA.

Ann N Y Acad Sci. 1997 Aug 14;823:97-106. Review.

PMID:
9292036
50.

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke.

Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, Brey RL, Coull B, Easton JD, Gomez CR, Helgason CM, Kase CS, Pullicino PM, Turpie AG.

Stroke. 1997 Jul;28(7):1501-6. No abstract available.

PMID:
9227707

Supplemental Content

Support Center